Literature DB >> 8888949

Apomorphine and 7-OH DPAT reduce ethanol intake of P and HAD rats.

R N Russell1, W J McBride, L Lumeng, T K Li, J M Murphy.   

Abstract

Adult male rats of the alcohol-preferring (P) line (N = 10) and high alcohol drinking (HAD) line (N = 12) were used to study the effects of IP administration of 0.125-0.50 mg/kg 7-OH DPAT (a putative D agonist) and 0.25-1.0 mg/kg apomorphine (a dopamine agonist with 50-fold higher affinities for the D1 and D2 receptors than for the D3 receptor) on the concurrent intakes of 10% (v/v) ethanol and 0.0125% (g/v) saccharin during a daily 4-h scheduled access period. Control intakes by the P rats for the 4-h period were 17.9 +/- 0.5 and 7.2 +/- 0.4 ml for the ethanol and saccharin solutions, respectively. For the HAD line, ethanol consumption was 18.7 +/- 0.2 ml and saccharin intake was 8.7 +/- 1.6 ml for the 4-h period. In terms of grams ethanol/kg body wt, the 4-h intakes were 2.2 +/- 0.2 for the P line and 3.0 +/- 0.3 for the HAD rats. Both P and HAD rats consumed approximately 40% of their total ethanol intake in the first 15 min of access while consuming only about 15% of their total saccharin intake during this 15-min period. The putative D3 agonist 7-OH DPAT produced a decrease in ethanol intake in the first h to 45-55% of control levels for the P rat (p < 0.01) and to 25-70% of control values in the HAD line (p < 0.001). Apomorphine caused a dose-dependent decrease in ethanol intake in the first hour to 15-70% of control values in the P rat (p < 0.001) and to 25-60% of control levels in the HAD line (p < 0.001). Saccharin and 4-h food intakes for both lines were not altered by either 7-OH DPAT or apomorphine. Overall, these results suggest that D2 and D3 dopamine receptors may play a role in mediating alcohol drinking behavior of the selectively bred HAD and P lines of rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888949     DOI: 10.1016/0741-8329(95)00062-3

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  9 in total

Review 1.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 2.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

Review 3.  Scheduled access alcohol drinking by alcohol-preferring (P) and high-alcohol-drinking (HAD) rats: modeling adolescent and adult binge-like drinking.

Authors:  Richard L Bell; Zachary A Rodd; Eric A Engleman; Jamie E Toalston; William J McBride
Journal:  Alcohol       Date:  2013-10-31       Impact factor: 2.405

Review 4.  Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Authors:  Bankole A Johnson
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

5.  Mechanisms of the influences of the central administration of substance P on ethanol consumption in chronically alcoholic rats.

Authors:  S V Nikolaev; E R Bychkov; A A Lebedev; S A Dambinova
Journal:  Neurosci Behav Physiol       Date:  2003-11

Review 6.  The alcohol-preferring (P) and high-alcohol-drinking (HAD) rats--animal models of alcoholism.

Authors:  William J McBride; Zachary A Rodd; Richard L Bell; Lawrence Lumeng; Ting-Kai Li
Journal:  Alcohol       Date:  2013-10-30       Impact factor: 2.405

7.  Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction.

Authors:  Claudio A Naranjo; Alan Y Chu; Lescia K Tremblay
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 8.  Neuropharmacology of alcohol addiction.

Authors:  V Vengeliene; A Bilbao; A Molander; R Spanagel
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

9.  Effects of the kappa opioid receptor antagonist, nor-binaltorphimine, on ethanol intake: impact of age and sex.

Authors:  Melissa Morales; Rachel I Anderson; Linda P Spear; Elena I Varlinskaya
Journal:  Dev Psychobiol       Date:  2013-06-10       Impact factor: 3.038

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.